Abstract:AIM: To investigate the clinical effects of laser photocoagulation combined with anti-vascular endothelial growth factor(VEGF)drugs at different time in the treatment of diabetic retinopathy(DR).METHODS: A prospective study was conducted. Totally 120 patients(191 diseased eyes)with DR who were admitted to the hospital between January 2018 and January 2019 were divided into group A(treated with simple laser photocoagulation, 30 cases, 44 diseased eyes), group B(treated with intravitreal injection of ranibizumab, 30 cases, 46 diseased eyes), group C(treated with intravitreal injection of ranibizumab after laser photocoagulation, 30 cases, 49 diseased eyes)and group D(treated with laser photocoagulation after intravitreal injection of ranibizumab, 30 cases, 52 diseased eyes). Patients in each group were followed up for 6mo after the end of treatment. The best corrected visual acuity(BCVA), intraocular pressure and central foveal thickness(CMT)of each group were compared before and after treatment. The situation of laser photocoagulation and anti-VEGF treatment, complications and recurrence of diabetic macular edema were observed.RESULTS: There was no significant difference in BCVA or CMT among the four groups before treatment(P>0.05). The two indexes were improved at 1wk, 1mo, 3mo and 6mo after treatment(P<0.05). Besides, they were better in group C and group D than in group A and group B at different time after treatment(P<0.05). The BCVA and CMT in group D were better than those in group C at 1wk, 1mo and 3mo after surgery(P<0.05). There was no significant difference in intraocular pressure among the four groups before or after treatment(P>0.05). The laser parameters and frequency of laser treatment were lower or fewer in group C and group D than in group A, and lower in group D than in group C(P<0.05). The frequencies of intravitreal injection in group C and group D were fewer than that in group B(P<0.05). There was no significant difference in the frequency of laser treatment or drug injection between groups C and group D(P>0.05). There was no significant difference in the incidence of complications or the incidence of diabetic macular edema among the four groups during follow up(P>0.05).CONCLUSION: The effect of laser photocoagulation after intravitreal injection of anti-VEGF drug is better than simple photocoagulation, simple intravitreal injection or intravitreal injection of ranibizumab after laser photocoagulation in the treatment of DR. It can improve the BCVA, relieve macular edema, reduce laser energy, frequency of laser treatment and injection frequency of anti-VEGF drug, with safety.

Effect Of Intravitreal Injection Of Bevacizumab-Chitosan Nanoparticles On Retina Of Diabetic Rats

Effect of an intravitreal injection of bevacizumab on the expression of VEGF and CD34 in the retina of diabetic rats: Bevacizumab a retinal anti-angiogenesis

Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.

Changes in Vitreous VEGF, Bfgf and Fibrosis in Proliferative Diabetic Retinopathy after Intravitreal Bevacizumab.

Experimental Study on the Inhibitory Effect of Bevacizumab on Choroidal Neovascularization in Rat

Inhibition of Neovascularization and Expression Shift of Pro-/Anti-Angiogenic Vascular Endothelial Growth Factor Isoforms after Intravitreal Bevacizumab Injection in Oxygen-Induced-Retinopathy Mouse Model

The Inhibitory Effect of Bevacizumab on Retinal Neovascularization in Oxygen-Induced Retinopathy in the Mouse

Effects Of Anti-Vegf Agents On Rat Retinal Muller Glial Cells

Effect of Intravitreal Injection of Bevacizumab on Optic Nerve Head Leakage and Retinal Ganglion Cell Survival in a Mouse Model of Optic Nerve Crush

Effects of Apelin and Vascular Endothelial Growth Factor on Central Retinal Vein Occlusion in Monkey Eyes Intravitreally Injected with Bevacizumab: a Preliminary Study.

Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab.

Intravitreal bevacizumab injection on idiopathic choroidal neovascularization

A Therapeutic Effect observation of 23 G Pars Plana Vitrectomy Assisted by Bevacizumab for Severe Proliferative Diabetic Retinopathy

Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy.

Effects of intravitreal Bevacizumab (Avastin) monotherapy in central retinal vein occlusion in young subjects

The investigation of Bevacizumab(Avastin)in preventing retinal microvascular proliferation in non-obese diabetes mice

Effect of Anti-VEGF drugs on diabetic Retinopathy-Microaneurysms: A correlation study

Ocular delivery of sunitinib-loaded nanoparticles doped in tragacanthic acid hydrogel in treatment of diabetic retinopathy in rats

Effects of Laser Photocoagulation Combined with Anti-Vegf Drugs at Different Time in the Treatment of Diabetic Retinopathy

Outcome of Intravitreal Bevacizumab for Idiopathic Choroidal Neovascularization in a Chinese Population

Effects of Angiotensin-Converting Enzyme Inhibitors and Β-Adrenergic Blockers on Retinal Vascular Endothelial Growth Factor Expression in Rat Diabetic Retinopathy